Integrating opportunities and parametrized signatures for improved mutational processes estimation in extended sequence contexts
Ragnhild Laursen 1,2,† , Marta Pelizzola 1,† , Lasse Maretty 2,3,4 , and Asger Hobolth 1 · 2026
Read Integrating opportunities and parametrized signatures for improved mutational processes estimation in extended sequence contexts by Ragnhild Laursen 1,2,† , Marta Pelizzola 1,† , Lasse Maretty 2,3,4 , and Asger Hobolth 1 (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2604-21662.txt.
Introduction
Ragnhild Laursen and colleagues sharpen mutational signature estimates by joining four add-ons to the usual setup: counting mutation chances, widening sequence context, using a negative binomial model, and setting signatures by formula. Mutational signatures track how often each base swap shows up with its near neighbors. The joined setup proves most useful when contexts span two or three neighbors on each side. Tests show the blend gives steady and trusted signatures in varied settings.
Catalog record
| CREATOR | Ragnhild Laursen 1,2,† , Marta Pelizzola 1,† , Lasse Maretty 2,3,4 , and Asger Hobolth 1 |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42319 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2604.21662
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Integrating opportunities and parametrized signatures for improved mutational processes estimation in extended sequence contexts Ragnhild Laursen 1,2,† , Marta Pelizzola 1,† , Lasse Maretty 2,3,4 , and Asger Hobolth 1 Abstract Abstract Mutational signatures describe the pattern of mutations over the different mutation types. Each mutation type is determined by a base substitution and the flanking nucleotides to the left and right of that base substitution. Due to the widespread interest in mutational signatures, several efforts have been devoted to the development of methods for robust and stable signature estimation. Here, we combine various extensions of the standard framework to estimate mutational signatures. These extensions include (a) incorporating opportunities to the analysis, (b) allowing for extended sequence contexts, (c) using the Negative Binomial model, and (d) parametrizing the signatures. We show that the combination of these four extensions gives very robust and reliable mutational signatures. In particular, we highlight the importance of including mutational opportunities and parametrizing the signatures when the mutation types describe an extended sequence context with two or three flanking nucleotides to each side of the base substitution. Keywords: Cancer genomics, mutational signatures, Negative Binomial, non-negative matrix factorization, opportunities, parametrization, sequence context. 1 Introduction 1.1 Mutational signatures in cancer genomics The collection of mutations observed in a cancer patient is often referred to as the mutational catalogue of the patient. In this context, mutations are usually defined by taking into account the base substitution and its right and left flanking nucleotides, i.e. using the single-base-substitution-96 (SBS-96) mutational context ( 2 ) . Nowadays the genome of numerous cancer patients have been sequenced and their mutational catalogues are available in public repositories such as the Pan-Cancer Analysis of Whole Genomes (PCAWG) database ( 27 ) . The catalogue of mutations observed in a cancer tissue is generated by a combination of different mutational processes acting on the cancer cells. From the large collections of sequenced data from patients it is possible to obtain mutational signatures (top row in Figure 1 ). These are probability vectors over the possible mutation types and each describes the pattern of a mutational process operative in the evolution of the cancer genomes. Cancer is mostly driven by few mutations in the genome, thus mutational signatures are highly important for distinguishing driver mutations from other processes taking place in the genome. A thorough understanding of mutational signatures and their associations with DNA repair deficiencies or exposures to certain agents can therefore play a key role for defining treatments for cancer patients ( 8 ) or developing prevention strategies ( 30 ) . Well known examples of mutational processes leaving distinctive signatures include aging ( 22 ) , UV light ( 23 ) and tobacco smoking ( 3 ) . Other examples and aetiologies of different mutational signatures can be found in 26 . Figure 1: A graphical representation of the methods incorporated in our model to obtain robust mutational signatures. Top row: The mutational count data V is factorized into an exposure matrix W , a mutational signature matrix H , and a diagonal matrix of opportunities O . Bottom row: Key ingredients of our model. The model assumes the Negative Binomial distribution for the counts (Negative binomial model), includes a parametrization of the signatures (Parametrized signatures for penta-nucleotide context), and takes into account the opportunity for each mutation type (Opportunities for penta-nucleotide context). Mutational signatures are usually identified using non-negative matrix factorization (NMF) ( 1 ; 18 ; 13 ; 20 ) . NMF takes as input a matrix of mutational catalogues for different patients and factorizes it into the product of two non-negative matrices. In our framework, these are a matrix of mutational signatures and a matrix of weights representing the contribution of each signature to the total mutation counts of the different patients. Different approaches to estimate the signatures from mutational count data are reviewed in 5 and 19 . 1.2 Sequence context and opportunities The mutation rate depends on the sequence context around each site ( 16 ; 9 ; 6 ) . Thus, it is essential to include the sequence context information around the base substitution when defining mutation types for the inference of mutational signatures (see bottom right illustration in Figure 1 ). The SBS-96 mutational context has been commonly used in the literature to define the mutation types for the mutational count matrix used as input in NMF. This definition can be extended by including two, three or more flanking nucleotides at each side of the base substitution to better capture the information carried out by the sequence context of each mutation. Extending the sequencing context in this way leads to more sparse data sets. Furthermore, sets of nucleotide sequences occur with very heterogeneous rates along the genome, which leaves different opportunities for the mutation types to occur. The opportunity of a mutation type describes the number of sites in the genome where that specific mutation type can occur. A higher opportunity for a specific mutation type gives a higher probability of observing a mutation from that type. The disparity in opportunities for different mutation types can be observed in the SBS-96 context, but becomes even more pronounced when looking at extended sequence contexts with two or three flanking nucleotides at each side. If the information contained in the opportunities is incorporated in the framework for estimating mutational signatures, the inferred signatures can be generalized regardless of the considered sequence composition (e.g. between whole genome and exome sequencing). Furthermore, by taking into account the sequence context in a genome, we obtain a more accurate estimation of the relative contribution of the different mutational processes. 1.3 Models for mutational count data Mutational opportunities have previously been used in 10 and 11 in connection with the classical Poisson model and in the SBS-96 sequence context. Recent work, however, has shown that mutational count data is over-dispersed (see bottom left illustration in Figure 1 ). As a result, the Negative Binomial model is better suited for modeling mutational count data than the Poisson model ( 18 ; 20 ) . Mutational opportunities have not yet been included in Negative Binomial NMF models to estimate mutational signatures, and their importance in extended sequence contexts still needs to be explored. Ignoring opportunities in NMF can cause an overestimation of the relative contribution of certain types of mutations compared to the overall mutational burden of the cancer genome. This can in turn lead to inaccurate conclusions about the underlying mutational processes. 1.4 Parametrized signatures Larger sequence contexts leads to an exponential increase of the number of parameters in the standard NMF parametrization. We include two alternatives to reduce the number of parameters in the model by parametrizing the mutational signatures (see bottom middle illustration in Figure 1 ) as described in 14 . This leads to more robust and interpretable signatures. We mainly investigate three types of parametrizations in this paper: the mono-nucleotide additive model of 24 , the di-nucleotide interaction model of 14 , and the standard Poisson-NMF model of 2 . 1.5 The full model and overview of the paper Our final model thereby, for any sequence context, integrates opportunities and parametrized signatures into a Negative-Binomial-NMF framework. A graphical representation of